BHWM
CERE

Beaird Harris Wealth Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Beaird Harris Wealth Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-265
Closed -$10.8K – 728
2024
Q2 		$10.8K Buy
+265
New +$11K ﹤0.01% 365

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Beaird Harris Wealth Management's CERE Position: Q3 2024 in Review

Beaird Harris Wealth Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 265 shares — an estimated $10.8K sold.

Beaird Harris Wealth Management first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $10.8K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Beaird Harris Wealth Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Beaird Harris Wealth Management sold 265 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $10.8K.
  • Beaird Harris Wealth Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • Beaird Harris Wealth Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $10.8K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Beaird Harris Wealth Management's 13F filing for Q3 2024, filed 2 Dec 2024.